SectorBiological Technology
Established Date13/12/1990
Listing Date31/05/2013
ExchangeNASDAQ Stock Exchange
Full-time Employees374
Fiscal Year Ends31/12
Security TypeCommon stock
Office address2 Holzman St., Weizmann Science Park, P.O Box 4081, Rehovot 7670402, Israel
BusinessPlasma-derived protein therapy companies that market existing rare combination drug products.
IntroductionKamada Ltd., was established in Israel on December 13, 1990. The company is a commercial-stage global biopharmaceutical company with a marketed product portfolio for rare and serious diseases, and is a leader in the field of specialized plasma derivation focusing on limited therapeutic alternative diseases. The company is also advancing an innovative development pipeline for areas with significant unmet medical needs. The company's strategy is focused on driving profitable growth from the company's important commercial catalysts and the company's manufacturing and development expertise in the plasma-derived and biopharmaceutical markets.
